Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02518048

A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris

Skin and Connective Tissue Diseases Clinical Trial

Official title:
A Phase 2a Trial Evaluating the Anti-psoriatic Effect of LEO 90100 Aerosol Foam Compared to Betesil® Medicated Plaster in the Treatment of Psoriasis Vulgaris

Clinical Trial Summary

The purpose of this study is to evaluate the anti-psoriatic effect of LEO 90100 aerosol foam compared with Betesil® medicated plaster

Clinical Trial Description

The products will be applied on 6 test sites (each product on 3 test sites) once daily 6 days a week (except Sundays) for 4 weeks. The application sites for each product will be determined according to random assignment. Depending on the size of the psoriasis plaques, 2 or 4 test sites will be located within the same plaque; the treatment assignment will be done pair-wise. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02518048
Study type Interventional
Source LEO Pharma
Contact
Status Completed
Phase Phase 2
Start date August 2015
Completion date January 2016
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04971200 - Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo Early Phase 1
Active, not recruiting NCT05525741 - Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients N/A
Completed NCT02379793 - Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects Phase 1
Completed NCT01093911 - Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) Phase 1
Completed NCT00147511 - Time To Efficacy and Onset Of Action Of Linezolid Phase 4
Completed NCT02355639 - A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin Phase 1
Completed NCT01764594 - Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus Phase 1
Active, not recruiting NCT05185258 - Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study Phase 4
Completed NCT02985437 - Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin Phase 1
Withdrawn NCT03196115 - Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)
Completed NCT02416258 - A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) Phase 2